Found: 10
Select item for more details and to access through your institution.
Primary immunodeficiencies Unravel the role of il-2/cD25/sTaT5b in human natural Killer cell Maturation.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.01429
- By:
- Publication type:
- Article
HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function.
- Published in:
- Frontiers in Immunology, 2016, p. 1, doi. 10.3389/fimmu.2016.00356
- By:
- Publication type:
- Article
Natural killer cells as helper cells in dendritic cell cancer vaccines.
- Published in:
- Frontiers in Immunology, 2015, v. 5, p. 1, doi. 10.3389/fimmu.2015.00013
- By:
- Publication type:
- Article
Tumor‐associated macrophages impair NK cell IFN‐γ production and contribute to tumor progression in clear cell renal cell carcinoma.
- Published in:
- European Journal of Immunology, 2024, v. 54, n. 6, p. 1, doi. 10.1002/eji.202350878
- By:
- Publication type:
- Article
Human Natural Killer Cell Maturation Defect Supports In Vivo CD56<sub>bright</sub> to CD56<sup>dim</sup> Lineage Development.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051677
- By:
- Publication type:
- Article
Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27.
- Published in:
- Frontiers in Immunology, 2017, v. 7/8, p. 1, doi. 10.3389/fimmu.2017.00025
- By:
- Publication type:
- Article
Expansion of CD11b<sup>+</sup>Ly6G<sup>+</sup>Ly6C<sup>int</sup> cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 12, p. 1781, doi. 10.1007/s00262-013-1483-x
- By:
- Publication type:
- Article
Immune Monitoring of Patients With Primary Immune Regulation Disorders Unravels Higher Frequencies of Follicular T Cells With Different Profiles That Associate With Alterations in B Cell Subsets.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.576724
- By:
- Publication type:
- Article
Leveraging NKG2D Ligands in Immuno-Oncology.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.713158
- By:
- Publication type:
- Article
Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.681615
- By:
- Publication type:
- Article